• News Releases

Genoa Healthcare’s handling of the pandemic featured in Chain Drug Review

Jun 8th, 2021

Increase in Mental Illness & Substance Abuse during Pandemic

As rates of mental illness and substance use disorder rose during the COVID-19 pandemic, Genoa Healthcare stepped up to improve access to care and promote better health care outcomes. Genoa’s efforts to meet the needs of the behavioral health community during the pandemic were featured recently in Chain Drug Review magazine. You can read the full article here or view it in the Chain Drug Review April issue.

The article highlights the growing need for behavioral health services and access to care and explains how Genoa pharmacies adapted to meet the changing needs of clinic partners and consumers. Pharmacies increased delivery and curbside pickup services, made proactive check-in calls and integrated with telehealth providers to ensure consumers were able to stay on their medication plans.

In addition, Genoa pharmacies have partnered with states and counties to administer COVID-19 vaccines in their local communities, ensuring that chronically underserved individuals had access to immunization clinics.

Read the full article for more information.

Recent Posts


  • Pharmacy Openings
Announcing six new pharmacy openings!

We’re excited to announce the opening of six pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve...

  • Pharmacy Openings
Announcing seven new pharmacy openings!

We’re excited to announce the opening of seven pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve their...

  • Blog Post
Genoa Healthcare® Pharmacists’ Trusting Consumer Relationships Aid in Support for Long-Acting Injectable Treatments

Providing Support for Long-Acting Injectable Treatments When a consumer who had recently been discharged from the hospital came into their Genoa pharmacy to receive a long-acting injectable (LAI) treatment for...

  • News Releases
New medication options in behavioral health

FDA Approves 14 New Medications The FDA has approved 14 new medication and treatment options for the behavioral health space to date in 2022. The new medication and treatment options...